US Patent Issued to Reverb Therapeutics on Oct. 27 for "Cytokine-based therapies and methods" (Canadian, American Inventors)

ALEXANDRIA, Va., Oct. 27 -- United States Patent no. 12,774,329, issued on Oct. 27, was assigned to Reverb Therapeutics Inc. (Vancouver, Canada).

"Cytokine-based therapies and methods" was invented by David De Graaf (Auburndale, Mass.), Mark Fogg (Vancouver, Canada), Surjit Bhimarao Dixit (Richmond, Canada) and Stacey Tom-Yew (Coquitlam, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to methods for redirecting an active form of an endogenous cytokine to a target cell or target tissue of interest in a biological system or subject in need thereof by administering a multi-specific binding molecule comprising (a) a binding domain that specifically binds to an active form of a cytoki...